Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
AFC-HD AMS Life Science Co., Ltd. ( (JP:2927) ) has provided an announcement.
AFC-HD AMS Life Science Co., Ltd. reported a modest 1.4% year-on-year increase in net sales to ¥16,846 million for the second quarter ended February 2026, but saw declines in profitability metrics, including a 3.4% drop in operating profit to ¥1,251 million and a 9.1% fall in profit attributable to owners of parent to ¥801 million. Despite weaker earnings, the company strengthened its financial position, with total assets rising to ¥50,254 million, net assets increasing to ¥16,224 million, and its capital adequacy ratio improving to 31.9%, suggesting a more solid balance sheet that may support future stability for stakeholders.
More about AFC-HD AMS Life Science Co., Ltd.
AFC-HD AMS Life Science Co., Ltd. is a Japan-based general business company listed on the Tokyo Stock Exchange Standard market. The company operates in the life science field, though specific primary products or services are not detailed in this disclosure, and it reports on a consolidated basis with a fiscal year ending August 31.
Average Trading Volume: 47,536
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen12.51B
For detailed information about 2927 stock, go to TipRanks’ Stock Analysis page.